A novel cyclodextrin-lipid complex method for formulating asymmetric liposomes and the complexation and asymmetry...

Area of Science:

• Biochemistry
• Materials Science
• Nanotechnology

Background:

• Liposomes are widely used as drug delivery systems.
• Recent research focuses on creating asymmetric liposomes for enhanced functionality.
• Maintaining liposome asymmetry is crucial for targeted drug delivery.

Purpose of the Study:

• To develop and optimize a novel cyclodextrin (CD)-lipid exchange method for formulating asymmetric liposomes.
• To confirm the complexation of lipids and cyclodextrins using various analytical techniques.
• To validate the asymmetry of the prepared liposomes and assess their stability.

Main Methods:

• Lipid-cyclodextrin complex formation in HEPES buffer.
• Preparation of large unilamellar vesicles (acceptor vesicles) via the thin film method.
• Lipid exchange facilitated by mixing CD-lipid complex and acceptor vesicles in a shaking water bath.
• Isolation of asymmetric liposomes through centrifugation.
• Confirmation of liposome asymmetry using zeta potential and fluorescence quenching.

Main Results:

• Successful formation of lipid-cyclodextrin complexes confirmed by FTIR, TGA, DSC, and NMR.
• Characterization of asymmetric liposomes using zeta potential and fluorescence quenching methods.
• Demonstrated enhanced stability of asymmetric liposomes compared to conventionally prepared ones.

Conclusions:

• The novel cyclodextrin-lipid exchange method provides a viable route for producing stable asymmetric liposomes.
• These asymmetric liposomes show improved stability, making them suitable for future drug delivery applications.
• Further studies will evaluate the encapsulation efficiency of these liposomes for various drug molecules.